A detailed history of California Public Employees Retirement System transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 137,594 shares of APLS stock, worth $3.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
137,594
Previous 173,574 20.73%
Holding current value
$3.6 Million
Previous $6.66 Million 40.4%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$28.84 - $41.15 $1.04 Million - $1.48 Million
-35,980 Reduced 20.73%
137,594 $3.97 Million
Q2 2024

Aug 14, 2024

BUY
$38.07 - $59.71 $1.06 Million - $1.66 Million
27,741 Added 19.02%
173,574 $6.66 Million
Q4 2023

Feb 01, 2024

SELL
$37.14 - $64.82 $1.41 Million - $2.46 Million
-38,011 Reduced 20.68%
145,833 $8.73 Million
Q3 2023

Nov 02, 2023

BUY
$23.65 - $89.22 $39,164 - $147,748
1,656 Added 0.91%
183,844 $6.99 Million
Q2 2023

Aug 09, 2023

BUY
$76.68 - $93.31 $3.08 Million - $3.75 Million
40,182 Added 28.3%
182,188 $16.6 Million
Q1 2023

May 12, 2023

SELL
$46.59 - $66.96 $2.33 Million - $3.35 Million
-49,958 Reduced 26.02%
142,006 $9.37 Million
Q4 2022

Feb 08, 2023

BUY
$43.24 - $61.04 $963,473 - $1.36 Million
22,282 Added 13.13%
191,964 $9.93 Million
Q3 2022

Nov 09, 2022

BUY
$44.76 - $69.66 $7.59 Million - $11.8 Million
169,682 New
169,682 $11.6 Million
Q2 2021

Aug 13, 2021

SELL
$40.9 - $64.9 $5 Million - $7.94 Million
-122,358 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$40.8 - $57.39 $718,896 - $1.01 Million
-17,620 Reduced 12.59%
122,358 $5.25 Million
Q4 2020

Feb 02, 2021

BUY
$30.79 - $57.2 $112,198 - $208,436
3,644 Added 2.67%
139,978 $8.01 Million
Q3 2020

Nov 05, 2020

BUY
$25.89 - $33.65 $90,615 - $117,775
3,500 Added 2.63%
136,334 $4.11 Million
Q2 2020

Aug 12, 2020

BUY
$24.8 - $38.49 $139,425 - $216,390
5,622 Added 4.42%
132,834 $4.34 Million
Q1 2020

May 12, 2020

BUY
$17.91 - $44.33 $310,075 - $767,485
17,313 Added 15.75%
127,212 $3.41 Million
Q4 2019

Jan 27, 2020

BUY
$22.1 - $30.8 $449,823 - $626,903
20,354 Added 22.73%
109,899 $3.37 Million
Q3 2019

Oct 31, 2019

BUY
$24.09 - $32.18 $1.1 Million - $1.47 Million
45,670 Added 104.09%
89,545 $2.16 Million
Q2 2019

Aug 15, 2019

BUY
$18.0 - $25.34 $121,284 - $170,740
6,738 Added 18.14%
43,875 $1.11 Million
Q4 2018

Feb 08, 2019

SELL
$11.47 - $18.71 $17,205 - $28,065
-1,500 Reduced 3.88%
37,137 $490,000
Q3 2018

Nov 13, 2018

SELL
$16.57 - $21.03 $137,183 - $174,107
-8,279 Reduced 17.65%
38,637 $687,000
Q2 2018

Aug 15, 2018

BUY
$19.63 - $30.0 $920,961 - $1.41 Million
46,916 New
46,916 $1.03 Million

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.88B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.